Middle East Healthcare Company
TADAWUL:4009.SR
72.6 (SAR) • At close September 19, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 180.176 | 81.218 | 19.232 | 99.676 | 95.283 | 172.249 | 272.963 | 361.86 | 390.249 | 331.969 | 137.198 | 61.994 |
| Afschrijvingen & Amortisatie
| 189.813 | 145.974 | 141.41 | 127.217 | 98.411 | 88.95 | 76.722 | 58.542 | 52.295 | 44.546 | 34.247 | 34.936 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -407.707 | -228.577 | -121.225 | -500.174 | -92.867 | -110.549 | -29.812 | -188.076 | -266.205 | -32.531 | -95.066 | -67.744 |
| Vorderingen
| -697.842 | -354.044 | -32.89 | -473.49 | -122.102 | -85.557 | 8.108 | -244.879 | -295.299 | -50.958 | -57.347 | -62.714 |
| Voorraden
| 85.473 | 5.581 | -1.14 | -33.74 | -10.306 | -6.646 | -20.802 | -13.643 | -1.127 | 22.88 | -16.691 | -5.03 |
| Crediteuren
| 132.562 | 124.13 | -59.929 | 21.908 | 66.702 | -3.531 | -26.119 | 67.062 | 27.952 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 72.101 | -4.245 | -27.266 | -14.852 | -27.161 | -14.814 | -9.01 | -22.152 | 2.27 | -4.453 | -21.028 | 0 |
| Overige Niet-Contante Posten
| 70.871 | 77.408 | 37.205 | 9.892 | -2.189 | -10.894 | 20.765 | 24.977 | 17.657 | 5.298 | 52.126 | -99.361 |
| Kasstroom uit Operationele Activiteiten
| 33.153 | 76.023 | 76.622 | -263.389 | 98.638 | 161.356 | 340.638 | 257.304 | 193.996 | 349.282 | 128.505 | -2.431 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -232.369 | -249.527 | -417.514 | -294.293 | -472.102 | -356.708 | -234.82 | -140.198 | -114.998 | -123.246 | -162.03 | -12.704 |
| Netto Overnames
| 0.381 | 0.131 | 0.126 | 0.481 | 3.252 | 1.382 | 1.869 | 1.467 | 13.883 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -10 | 0.128 | -0.827 | 3.628 | 2.465 | -355.326 | -1.413 | -1.07 | 0 | 0 | 3.946 | 0.342 |
| Kasstroom uit Investeringsactiviteiten
| -241.989 | -249.396 | -417.388 | -290.184 | -468.85 | -355.326 | -234.82 | -140.198 | -114.998 | -123.246 | -158.084 | -12.363 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -256.716 | -937.005 | -695.675 | -522.504 | -383.825 | -313.501 | -17.527 | -164.222 | -5.798 | -2.543 | -6.348 | -6.25 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | -184.08 | -184.08 | -184.08 | -165.672 | -92.04 | -19.769 | 0 |
| Overige Financieringsactiviteiten
| -157.93 | 1,097.85 | 1,047.661 | 1,039.105 | 763.701 | 127.135 | 34.225 | 166.265 | 6.248 | -44.303 | 72.709 | 18.342 |
| Kasstroom uit Financieringsactiviteiten
| 237.657 | 160.845 | 351.986 | 516.601 | 379.876 | 127.135 | -149.855 | -17.815 | -159.424 | -133.8 | 59.288 | 18.342 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 28.821 | -12.528 | 11.219 | -36.973 | 9.664 | -66.835 | -44.037 | 99.29 | -80.426 | 92.236 | 29.709 | 3.549 |
| Kaspositie aan het Einde van de Periode
| 44.423 | 15.602 | 28.129 | 16.91 | 53.883 | 44.219 | 111.054 | 155.091 | 55.8 | 136.226 | 43.991 | 14.282 |